APA

Rotow J. K., Woodard G. A., Urisman A., McCoach C. E., Bivona T. G., Elicker B. M., Jablons D. M. & Blakely C. M. (20190625). Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation. : Clinical lung cancer.

Chicago

Rotow Julia K, Woodard Gavitt A, Urisman Anatoly, McCoach Caroline E, Bivona Trever G, Elicker Brett M, Jablons David M and Blakely Collin M. 20190625. Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation. : Clinical lung cancer.

Harvard

Rotow J. K., Woodard G. A., Urisman A., McCoach C. E., Bivona T. G., Elicker B. M., Jablons D. M. and Blakely C. M. (20190625). Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation. : Clinical lung cancer.

MLA

Rotow Julia K, Woodard Gavitt A, Urisman Anatoly, McCoach Caroline E, Bivona Trever G, Elicker Brett M, Jablons David M and Blakely Collin M. Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation. : Clinical lung cancer. 20190625.